Violation Tracker Individual Record

Company: 
Boehringer Ingelheim Pharmaceuticals, Inc.
Current Parent Company: 
Boehringer Ingelheim
Penalty: 
$13,500,000
Year: 
2017
Date: 
December 20, 2017
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Violation Description: 

Boehringer Ingelheim Pharmaceuticals, Inc. agreed to pay $13.5 million to settle multistate litigation alleging deceptive and misleading representation and off-label marketing of its prescription drugs.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Multistate Attorneys General Case
Civil or Criminal Case: 
civil
HQ Country of Parent: 
Germany
Ownership Structure of Parent: 
privately held
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.